RA0245

antibody from Oursmab

Targeting: FCGRT alpha-chain, FCRN

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0245

Provider

Oursmab

Product name

Nipocalimab (Biosimilar Reference Antibody) (FCGRT)

Antibody type

Monoclonal

Description

Nipocalimab (also known as M281) is a fully human, anti-neonatal Fc receptor (FcRn) monoclonal antibody of the IgG1 isotype. It is designed to bind with high affinity to FcRn and block its interaction with IgG, thereby accelerating the catabolism of endogenous pathogenic IgG antibodies. By lowering circulating IgG levels, including autoantibodies and alloantibodies, it aims to treat autoimmune and alloimmune diseases driven by pathogenic IgG. It is being developed for a range of conditions, including warm autoimmune hemolytic anemia (wAIHA), fetal and neonatal alloimmune thrombocytopenia (FNAIT), myasthenia gravis (MG), and other IgG-mediated disorders.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.